Skip to content

Effect of Varying Doses of Compound Betamethasone Combined with Ropivacaine for S-FICB in Elderly Femoral Head Replacement: A Randomized Controlled Trial

Effect of Varying Doses of Compound Betamethasone Combined with Ropivacaine for S-FICB in Elderly Femoral Head Replacement: A Randomized Controlled Trial - Clinical Efficacy of Ropivacaine plus Compound Betamethasone for Fascia Iliaca Compartment Block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126803
Enrollment
Unknown
Registered
2026-06-16
Start date
2026-06-18
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fracture

Interventions

Control Group (Group C):Ropivacaine iliac fascia gap block above the inguinal ligament.
High-dose Compound Betamethasone Group (Group BH):Ropivacaine + 7mg Compound Betamethasone Iliac Fascia Block.
Low-dose Compound Betamethasone Group (Group BL):Ropivacaine + 3.5mg Compound Betamethasone Iliac Fascia Block.

Sponsors

Chengde Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age greater than 65 years, with a body mass index (BMI) between 18.5 and 28 kg/m^²; 2. American Society of Anesthesiologists (ASA) physical status classification II–III, scheduled for elective unilateral hemiarthroplasty for femoral neck fracture; 3. Preoperative coagulation function, complete blood count, and electrocardiogram findings were essentially normal; 4. Subjects voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Those who are allergic to the drugs used in this study, or have contraindications to nerve block and combined spinal-epidural anesthesia. 2.Definite history of diabetes mellitus, chronic pain, or long-term use of glucocorticoids or opioid medications; 3.Severe disturbance of consciousness, psychiatric disorders, or communication impairment preventing cooperation with assessment; 4.Concomitant multiple trauma, septic shock, or skin breakdown at the puncture site.

Design outcomes

Primary

MeasureTime frame
Block analgesic duration;Quadriceps Muscle Strength Assessment;

Countries

China

Contacts

Public ContactLiuzhong

Chengde Central Hospital

1073405026@qq.com+86 314 202 8712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026